Approval · Notice of Compliance 33554 · 2024
ADDYI: Notice of Compliance 33554
Issued July 3, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33554
- Date
- July 3, 2024
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site and/or manufacturer involving production of the starting material. Addition of a manufacturing site and/or manufacturer involving production of the drug substance. Replacement of a manufacturing site and/or manufacturer involving production of the drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADDYI | Not yet assigned | — |
Medicinal ingredients
- FLIBANSERIN 100 MG per TAB